(4-(2-Hydroxyethyl)piperazin-1-yl)(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone

Catalog No. :
ACZAFX486
CAS No. :
1112789-86-2
Molecular Formula :
C19H29BN2O4
Molecular Weight :
360.26

IUPAC Name:(4-(2-hydroxyethyl)piperazin-1-yl)(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone

(4-(2-Hydroxyethyl)piperazin-1-yl)(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$220.00Login to see priceInquiryInquiry
100mg95%$325.00Login to see priceInquiryInquiry
250mg95%$461.00Login to see priceInquiryInquiry
1g95%$921.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-(2-Hydroxyethyl)piperazin-1-yl)(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone
IUPAC Name(4-(2-hydroxyethyl)piperazin-1-yl)(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone
Molecular FormulaC19H29BN2O4
Molecular Weight360.26
SMILESO=C(N1CCN(CC1)CCO)C2=CC(B3OC(C)(C(C)(C)O3)C)=CC=C2
InChI KeyXTGVPNNTXXGAKO-UHFFFAOYSA-N
Synonym[4-(2-Hydroxyethyl)-1-piperazinyl][3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanone
CAS No.1112789-86-2

Synthetic Route by SureRoute

1. ACZAFX486 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEGVT713 route compound structure diagram
    ACEGVT713269409-73-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZAFX486 route product structure diagram
    ACZAFX4861112789-86-2
Inquiry

2. ACZAFX486 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZAFX486 route product structure diagram
    ACZAFX4861112789-86-2
Inquiry

Comments (0)